Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Fallopian Tube Neoplasms 2Uterine Cervical Neoplasms 1Turcot syndrome 1Stomach Neoplasms 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms, Squamous Cell 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

taxane 2Surgical Procedures, Operative 2Poly(ADP-ribose) Polymerase Inhibitors 2Neoadjuvant Therapy 2Carboplatin 2Bevacizumab 2olaparib 1niraparib 1cediranib 1Platinum 1Paclitaxel 1Maintenance 1Etoposide 1Drug Therapy 1Diagnostic Imaging 1CP protocol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Fallopian Tube Neoplasms × Neoadjuvant Therapy × Clear all
NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting
220 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04515602 2020-08-27

FOCUS

Shanghai Gynecologic Oncology Group

Phase 3 Not yet recruiting
410 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡